(Lakewood, NJ, January 22, 2026) – CareTria (“Company”), a leading therapy initiation platform backed by Frazier Healthcare Partners (“Frazier”), today announced the appointment of Matt Wolf as Chief Commercial Officer. In his role, Matt will lead CareTria’s commercial organization, partnering with pharma, providers, and payers to deliver a faster path from order to therapy.
CareTria delivers an integrated approach to therapy initiation designed to reduce friction at every step of the patient journey. By combining a deep provider network, advanced digital enrollment and multi-modal fulfillment, CareTria helps accelerate patient starts while optimizing gross-to-net performance for its pharma partners.
“CareTria was built to address one of the most persistent challenges in healthcare, helping patients start therapy without unnecessary delay,” said Willis Chandler, President & CEO of CareTria. “Matt’s deep experience across pharmacy and pharma services, along with his proven ability to drive cross-functional execution, will be critical as we scale our end-to-end platform.”
Experienced Commercial Leader with Proven Healthcare Track Record
Wolf joins CareTria from Cencora, where he most recently served as President of Biopharma Services, leading digital technologies, patient support services, pharmacy services and field-based solutions supporting biopharmaceutical manufacturers. His experience spans pharmacy practice, distribution services, and commercial operations, positioning him to lead CareTria’s commercial strategy at a pivotal moment in the company’s growth.
He holds a Bachelor of Science in Pharmacy from Ohio Northern University and an MBA from Penn State University and is a licensed pharmacist.
Driving Commercial Excellence at CareTria
As Chief Commercial Officer, Wolf will be responsible for advancing CareTria’s market expansion, optimizing customer solutions, and reinforcing the company’s ability to be a unified partner for integrated therapy initiation.
“I’m excited to join CareTria as the Company continues to redefine how patients access therapy,” said Matt. “I look forward to working closely with our customers to solve problems and meet business objectives in this increasingly complex access environment.”
About CareTria
CareTria is a leading therapy initiation partner that helps pharma companies accelerate patient conversions and optimize gross-to-net through a faster path from order to therapy. Its exclusive provider network with embedded automated digital enrollment, including 85% of benefit investigations completed in under 60 seconds, connected to multi-modal fulfillment – including specialty pharmacy, direct-to-patient cash, samples, free-goods, and 3PL distribution – ensures a faster path from order to therapy. Real-time data and analytics drive continuous optimization across the product journey. By combining speed, precision, and scale, CareTria helps patients start therapy sooner while delivering measurable impact for its pharma partners. Learn more at www.caretria.com/pharma.
About Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $11 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 34 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier is headquartered in Seattle, WA, with an office in New York City, and invests broadly across the U.S., Canada, and Europe. For more information about Frazier, visit www.frazierhealthcare.com/home.
